Preferred Label : Sunitinib;

MeSH definition : An indole and pyrrole derivative that inhibits VEGF-R2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.; An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.;

MeSH synonym : 5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide;

MeSH hyponym : SU011248; SU 011248; SU-011248; SU11248; SU-11248;

MeSH Related Number : LVX8N1UT73;

Wikipedia link : https://en.wikipedia.org/wiki/Sunitinib;

UNII : V99T50803M;

Details


Main resources

You can consult :

An indole and pyrrole derivative that inhibits VEGF-R2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.
An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.

https://www.has-sante.fr/jcms/p_3513274/fr/sunitinib-zentiva-sunitinib-oncologie
2024
false
false
false
France
evaluation of the transparency committee
Sunitinib Malate
Oncologist
Sunitinib
Oncology
Sunitinib
Oncologists

---
https://www.has-sante.fr/jcms/p_3456524/fr/sutent-sunitinib-tumeur-neuroendocrine-du-pancreas-pnet
2023
false
false
false
France
Unresectable Pancreatic Neuroendocrine Neoplasm
Metastatic Pancreatic Neuroendocrine Tumor
treatment outcome
insurance, health, reimbursement
protein kinase inhibitors
sunitinib
disease progression
adult
administration, oral
evaluation of the transparency committee
pancreatic neoplasms
neuroendocrine tumors
Sunitinib

---
https://www.ema.europa.eu/en/medicines/human/EPAR/sunitinib-accord
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Sunitinib
Sunitinib
sunitinib
drugs, generic
adult
gastrointestinal stromal tumors
kidney neoplasms
neoplasm metastasis
pancreatic neoplasms
Pancreatic Neuroendocrine Tumor
Metastatic Kidney Carcinoma
neuroendocrine tumors
administration, oral
protein kinase inhibitors
protein kinase inhibitors
aged
drug interactions
pregnancy
breast feeding
angiogenesis inhibitors
angiogenesis inhibitors
survival analysis
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3265889/fr/sunitinib-biogaran-sunitinib
2021
false
false
false
France
sunitinib
administration, oral
drugs, generic
Product containing only sunitinib in oral dose form (medicinal product form)
adult
gastrointestinal stromal tumors
neoplasm metastasis
protein kinase inhibitors
Metastatic Gastrointestinal Stromal Tumor
treatment outcome
insurance, health, reimbursement
Unresectable Malignant Gastrointestinal Stromal Tumor
carcinoma, renal cell
Advanced Kidney Carcinoma
Metastatic Pancreatic Neuroendocrine Tumor
Metastatic Kidney Carcinoma
Unresectable Pancreatic Neuroendocrine Neoplasm
evaluation of the transparency committee
Sunitinib

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-VEGFR-axitinib-cabozantinib-pazopanib-sorafenib-sunitinib
2019
false
false
false
France
Axitinib
cabozantinib
pazopanib
Sorafenib
Sunitinib
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
risk factors
patient education as topic
continuity of patient care
administration, oral
receptors, vascular endothelial growth factor
carcinoma, renal cell
drug interactions
pregnancy
Tyrosine Kinase Inhibitors
guidelines for drug use
Sorafenib
pazopanib
Axitinib
Sunitinib
cabozantinib
pyrimidines
sulfonamides
anilides
pyridines
pyrimidines
sulfonamides
anilides
pyridines
anilides
pyridines
pyrimidines
sulfonamides

---
http://www.conseil-scientifique.public.lu/fr/publications/oncologie/sunitinib.html
2016
false
false
true
Luxembourg
French
guidelines for drug use
antineoplastic agents
administration, oral
sunitinib
protein kinase inhibitors
receptor Protein-Tyrosine kinases
treatment outcome
survival analysis
Progression-Free survival
kidney neoplasms
neoplasm metastasis
Metastatic Kidney Carcinoma
adult
gastrointestinal stromal tumors
pancreatic neoplasms
Pancreatic Neuroendocrine Tumor
neuroendocrine tumors
Advanced Malignant Neoplasm
Unresectable Malignant Neoplasm
Tyrosine Kinase Inhibitors
disease-free survival
indoles
pyrroles
Sunitinib

---
http://www.has-sante.fr/portail/jcms/c_2586921/fr/sutent
http://www.has-sante.fr/portail/jcms/c_545515/fr/sutent
2015
false
France
French
sunitinib malate
Metastatic Kidney Carcinoma
neuroendocrine tumors
pancreatic neoplasms
insurance, health, reimbursement
Pancreatic Neuroendocrine Tumor
Pancreatic neuroendocrine tumor metastatic
Advanced Malignant Neoplasm
adult
sunitinib malate
evaluation of the transparency committee
carcinoma, renal cell
gastrointestinal stromal tumors
administration, oral
treatment outcome
angiogenesis inhibitors
antineoplastic agents
indoles
pyrroles
indoles
pyrroles
antineoplastic agents
angiogenesis inhibitors
sunitinib
neoplasm metastasis
Sunitinib
Sunitinib

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/35473a-fra.php
2013
false
Canada
French
English
sunitinib malate
administration, oral
stevens-johnson syndrome
sunitinib
antineoplastic agents
pharmacovigilance note
indoles
pyrroles
Sunitinib

---
https://www.ema.europa.eu/medicines/human/EPAR/Sutent
2012
false
United Kingdom
English
French
syndication feed
sunitinib malate
Tyrosine Kinase Inhibitors
receptor, platelet-derived growth factor alpha
receptor, platelet-derived growth factor beta
vascular endothelial growth factor receptor-1
vascular endothelial growth factor receptor-2
indoles
pyrroles
antineoplastic agents
kidney neoplasms
gastrointestinal stromal tumors
treatment outcome
drug evaluation
sunitinib
vascular endothelial growth factor receptor-3
protein kinase inhibitors
angiogenesis inhibitors
summary of product characteristics
drug evaluation
package leaflet
Sunitinib

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00141
2011
false
false
false
Canada
drug information
malates
capsules
Sutent
sunitinib malate
Sunitinib

---
http://www.has-sante.fr/portail/jcms/c_1104028/sutent
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-10/sutent_-_ct-10136.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/sutent_ct_10136.pdf
2011
false
France
French
English
evaluation of the transparency committee
indoles
pyrroles
sunitinib malate
administration, oral
sunitinib
antineoplastic agents
pancreatic neoplasms
adult
neoplasm metastasis
neuroendocrine tumors
insurance, health, reimbursement
treatment outcome
disease-free survival
Sunitinib

---
http://www.has-sante.fr/portail/jcms/c_1191371/sutent-sunitinib-inhibiteur-de-tyrosine-kinase-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1191370/sutent-21092011-synthese-ct10136
http://www.has-sante.fr/portail/jcms/c_1106750/sutent-ct-10136
2011
false
France
French
guidelines for drug use
evaluation of the transparency committee
indoles
indoles
pyrroles
pyrroles
survival analysis
sunitinib malate
sunitinib malate
administration, oral
sunitinib
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
adult
pancreatic neoplasms
neuroendocrine tumors
neoplasm metastasis
disease progression
clinical trials, phase ii as topic
randomized controlled trials as topic
treatment outcome
Sunitinib
Sunitinib

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Guide_utilisation_Sunitinib_cancer_du_rein_m%C3%A9tastatique__(2010-07).pdf
2010
false
false
Canada
French
sunitinib malate
sunitinib malate
kidney neoplasms
neoplasm metastasis
carcinoma
antineoplastic agents
antineoplastic agents
indoles
indoles
pyrroles
pyrroles
drug evaluation
guidelines for drug use
Sunitinib
Sunitinib

---
http://www.meddispar.fr/medicaments/3821022
2008
false
France
French
pyrroles
capsules
indoles
administration, oral
drug prescriptions
legislation, drug
drug monitoring
continuity of patient care
sunitinib
sunitinib malate
drug information
Sunitinib

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Sunitinib_et_tumeurs_stromales_gastro-intestinales_(2008-04).pdf
2008
false
false
Canada
French
angiogenesis inhibitors
indoles
antineoplastic agents
pyrroles
gastrointestinal stromal tumors
bibliography of medicine
quebec
Evidence-Based medicine
gastrointestinal stromal tumors
adult
survival rate
neoplasm metastasis
sunitinib
sunitinib malate
guidelines for drug use
Sunitinib

---
http://www.meddispar.fr/medicaments/3821045
2008
false
France
French
capsules
indoles
pyrroles
administration, oral
drug monitoring
continuity of patient care
drug prescriptions
legislation, drug
sunitinib
sunitinib malate
drug information
Sunitinib

---
http://www.meddispar.fr/medicaments/3821039
2008
false
France
French
sunitinib malate
indoles
pyrroles
drug prescriptions
legislation, drug
administration, oral
continuity of patient care
capsules
drug monitoring
sunitinib
drug information
Sunitinib

---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14024a-fra.php
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14495a-fra.php
2008
false
Canada
French
English
Bevacizumab
angiogenesis inhibitors
indoles
pyrroles
carcinoma, renal cell
neoplasm metastasis
antineoplastic combined chemotherapy protocols
united states
anemia, hemolytic
purpura, thrombotic thrombocytopenic
pharmacovigilance note
Sunitinib

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Sutent_March-28-07_fr.pdf
2007
false
Canada
French
sunitinib malate
angiogenesis inhibitors
antineoplastic agents
indoles
pyrroles
gastrointestinal stromal tumors
sunitinib
drug evaluation
Sunitinib

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_Sutent_CEDAC%20Recommendation_fr_final.pdf
2007
false
Canada
French
sunitinib malate
kidney neoplasms
angiogenesis inhibitors
pyrroles
antineoplastic agents
indoles
sunitinib
drug evaluation
Sunitinib

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.